How should melatonin be dosed for sleep, and what precautions or alternative sleep aids should be considered?

Melatonin Should NOT Be Used as a Primary Treatment for Chronic Insomnia in Adults

The American Academy of Sleep Medicine explicitly recommends AGAINST using melatonin for treating sleep onset or sleep maintenance insomnia in adults. 111 This recommendation is based on weak evidence showing that melatonin (at 2 mg doses) provides minimal benefit—reducing sleep latency by only 9 minutes compared to placebo, with harms approximately equal to benefits.

Why Melatonin Fails as a Sleep Aid

The fundamental issue is that melatonin is a chronobiotic (circadian rhythm regulator), not a hypnotic (sleep-inducing agent). 2 Its primary mechanism is phase-shifting the circadian clock, not directly inducing sleep. When used incorrectly—which is most of the time—it provides negligible benefit:

• Sleep latency reduction: Only 9 minutes versus placebo 1
• Total sleep time improvement: Only 12 minutes versus placebo 1
• Quality of sleep: Small improvement at best 1

The widespread misuse stems from treating it as a "natural sleeping pill" taken reflexively at bedtime, rather than understanding its timing-dependent circadian effects. 23

Better Alternatives for Insomnia

For Sleep Onset Insomnia:

1. Ramelteon 8 mg (melatonin receptor agonist) - specifically targets melatonin receptors with more consistent pharmacology 11
2. Zaleplon 10 mg - for sleep onset specifically 11
3. Zolpidem 10 mg - for both onset and maintenance 11

For Sleep Maintenance Insomnia:

1. Doxepin 3-6 mg - specifically for maintenance issues 11
2. Suvorexant 10-20 mg - orexin receptor antagonist, reduces wake after sleep onset by 16-28 minutes 14
3. Eszopiclone 2-3 mg - for both onset and maintenance 11

For Both Onset and Maintenance:

• Temazepam 15 mg - improves total sleep time by 99 minutes versus placebo 1
• Eszopiclone 2-3 mg - moderate-to-large improvement in sleep quality 1

When Melatonin MIGHT Be Appropriate

Melatonin has legitimate uses, but only in specific circadian rhythm disorders:

Circadian Rhythm Sleep-Wake Disorders:

• Delayed Sleep-Wake Phase Disorder: 0.3-0.5 mg administered 5-6 hours before desired sleep time (NOT at bedtime) 23
• Jet lag: Timed to the destination time zone
• Shift work disorder: Timed appropriately for phase advancement

Critical timing principle: Melatonin administered 1-2 hours before habitual bedtime (around 6 PM for most people) optimizes circadian phase-shifting effects. 3 Taking it at bedtime when endogenous levels are already elevated provides minimal additional benefit.

Dosing Considerations:

• Physiological dose: 0.3 mg mimics natural secretion 5
• Pharmacological dose: 5 mg may increase sleep duration in older adults during both day and night 5
• Common OTC doses: 3-5 mg, though optimal dosing remains unclear 67

Critical Pitfalls to Avoid

1. Misdiagnosing circadian disorders as primary insomnia: A patient with delayed sleep-wake phase disorder will fail standard insomnia treatments. Look for consistent inability to fall asleep until 2-4 AM with normal sleep quality once asleep. 2

2. Wrong timing: Bedtime administration when the problem is phase delay wastes the chronobiotic effect. 23

3. Unregulated formulations: In the U.S., melatonin is a dietary supplement with no FDA oversight. Actual melatonin content varies wildly from labeled doses. 28

4. Ignoring better alternatives: Ramelteon provides more consistent melatonin receptor activation without formulation variability. 14

5. Supraphysiological dosing without rationale: Most people use 3-5 mg when 0.3 mg may be more appropriate for circadian effects. 5

Safety Profile

Short-term melatonin use appears safe with minimal adverse effects (mainly drowsiness 28.8%, headache 25.1%). 7 However:

• Long-term safety data remains insufficient 8
• No regulatory oversight of manufacturing in the U.S. 28
• Drug interactions and contraindications are poorly characterized
• Elderly patients show decreased endogenous production, but evidence for supplementation benefit is mixed 3

Medications to AVOID

The AASM also recommends AGAINST:

• Diphenhydramine (no improvement in sleep quality, anticholinergic burden) 11
• Trazodone 50 mg (harms outweigh benefits) 11
• L-tryptophan 1
• Valerian 1

Bottom line: If a patient presents requesting melatonin for insomnia, first determine if they have a circadian rhythm disorder versus true insomnia. For chronic insomnia, prescribe an evidence-based hypnotic from the AASM guidelines. Reserve melatonin for appropriately diagnosed circadian disorders with proper timing and dosing, or consider ramelteon for more reliable melatonin receptor agonism.